Open AccessCRLX101, a Nanoparticle–Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α
Author(s) -
Xi Tian,
Nguyễn Minh Thủy,
Henry P. Foote,
Joseph M. Caster,
Kyle C. Roche,
Christian Peters,
Pauline Wu,
Lata Jayaraman,
Edward G. Garmey,
Joel E. Tepper,
Scott Eliasof,
Andrew Z. Wang
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/7dn3-jk30
Subject(s) - camptothecin , conjugate , colorectal cancer , drug , chemoradiotherapy , cancer research , medicine , cancer , oncology , chemistry , pharmacology , biochemistry , mathematical analysis , mathematics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom